Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-323547.17%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 17.38Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -171.48M | -323547.17% | $ 53K |
| 3/31/2025 | $ -175.12M | -301924.14% | $ 58K |
| 12/31/2024 | $ -162.39M | -266219.67% | $ 61K |
| 9/30/2024 | $ -155.79M | -247280.95% | $ 63K |
| 6/30/2024 | $ -158.43M | -293390.74% | $ 54K |
| 3/31/2024 | $ -159.5M | -234555.88% | $ 68K |
| 12/31/2023 | $ -163.69M | -125918.46% | $ 130K |
| 9/30/2023 | $ -163.33M | -336.73% | $ 48.5M |
| 6/30/2023 | $ -162.74M | -335.68% | $ 48.48M |
| 3/31/2023 | $ -167.91M | -199.44% | $ 84.19M |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) OCF % stands at -2074.19%.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average OCF % has been -112471.79%.
- The median OCF % for LYELL IMMUNOPHARMA INC during this period was -1839.24%
- LYELL IMMUNOPHARMA INC reached its highest OCF % over the past 5 years at -199.44%.
- The lowest OCF % recorded by LYELL IMMUNOPHARMA INC in the same timeframe -323547.17%
LYELL IMMUNOPHARMA INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for LYELL IMMUNOPHARMA INC is calculated as follows: CF - Operations [ $ -160.87M ] / Revenues [ $ 7.76M ]
(=) OCF % [ -2074.19% ] LYEL - Operating Cash Flow Margin, Last 5 years
-323547.17%
Minimum
Jun 30, 2025
-199.44%
Maximum
Mar 31, 2023
-112471.79%
Average
-1839.24%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.31% |
| median | 12.65% |
| std | 21.13% |